Compare Johnson & Johnson (JNJ) vs iShares 20 Plus Year Treasury Bond ETF (TLT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Johnson & Johnson vs iShares 20 Plus Year Treasury Bond ETF — how do they compare? Johnson & Johnson trades at $260.9 (market cap $618.09B), while iShares 20 Plus Year Treasury Bond ETF trades at $77.9 (market cap $47.61B). The key difference: Johnson & Johnson is far larger — about 13× iShares 20 Plus Year Treasury Bond ETF's market cap, and Johnson & Johnson pays a 2.09% dividend while iShares 20 Plus Year Treasury Bond ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Johnson & Johnson for 129 Days and iShares 20 Plus Year Treasury Bond ETF for 83 Days on average.
| JNJ | TLT | |
|---|---|---|
Market Cap | $618.09B | $47.61B |
Volume | 6,050,983 | 49,263,490 |
Sector | Health | Fixed Income |
52-Week High | $278.43 | $92.06 |
52-Week Low | $186.00 | $77.11 |
Typical Hold Time | 129 Days | 83 Days |
Enterprise Value | $646.37B | — |
Dividend Yield | 2.09% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Johnson & Johnson (JNJ) trades at $259.62, up 0.45% with a bearish technical signal despite recent earnings beats. The stock shows strong fundamentals with 21.48% net margin and 25.74% ROE, though valuation ratios appear elevated with P/E at 29.75. Recent news highlights growth in the Innovative Medicine segment and positive analyst coverage with 52.5% buy ratings.
JNJ offers stable dividend income and pharmaceutical innovation upside, but faces patent cliff risks and increasing debt-to-asset ratio (24.06% in 2025). Analyst consensus target of $286.53 suggests 10% upside potential, though technical resistance at $260 may limit near-term gains.
TLT, the iShares 20+ Year Treasury Bond ETF, is trading at $77.83 with a 0.89% daily gain amid a challenging bond market environment. The ETF has declined 11% year-to-date and 46% over five years as Treasury yields reach multi-decade highs. Technical indicators show a bearish trend with moving averages signaling sell pressure, while oscillators remain neutral. Recent news highlights significant bond market volatility with Treasury yields hitting levels not seen since 2007.
The outlook for TLT remains heavily dependent on interest rate direction, with current high yields presenting both income opportunity and continued price risk. Key risks include persistent inflation pressures and Federal Reserve policy uncertainty. Investors should weigh the attractive yield against potential further bond price declines if rates continue rising.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →About iShares 20 Plus Year Treasury Bond ETF
The fund will invest at least 80% of its assets in the component securities of the underlying index, and it will invest at least 90% of its assets in US Treasury securities that the advisor believes will help the fund track the underlying index. The underlying index measures the performance of public obligations of the US Treasury that have a remaining maturity greater than or equal to twenty years.
Read more on TLT →
